Since AngII has a direct TRPC6-mediated calcium signaling (219, 220) which results in ROS expression (221) and proteinuria (222), inhibiting TRPC6 indirectly via AngII blockade is a feasible strategy in proteinuric diseases such as FSGS. Here, AGT is linked to focal segmental glomerulosclerosis.